CRISPR-Cas9 Screening Identifies Therapeutic Targets for AML1-ETO Positive Leukemia

被引：0
|
作者：
Guo, Chengcai [1 ]
Liu, Yu [1 ]
Rao, Qing [1 ]
Qiu, Shaowei [2 ]
Gu, Runxia [2 ]
Wang, Min [2 ]
Wang, Jianxiang [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Natl Clin Res Ctr Blood Dis, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol, Haihe Lab Cell Ecosyst,Inst Hematol & Blood Dis H, Tianjin, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-179262
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Identifying novel therapeutic targets in gastric cancer using genome-wide CRISPR-Cas9 screening
    Zeng, Zhi
    Zhang, Xu
    Jiang, Cong-Qing
    Zhang, Yong-Gang
    Wu, Xue
    Li, Jin
    Tang, Shan
    Li, Lang
    Gu, Li-Juan
    Xie, Xiao-Yu
    Jiang, Ying-An
    ONCOGENE, 2022, 41 (14) : 2069 - 2078
  • [22] CRISPR-Cas9 Screen Identifies XPO7 As a Potential Therapeutic Target for TP53-Mutated AML
    Semba, Yuichiro
    Yamauchi, Takuji
    Nakao, Fumihiko
    Nogami, Jumpei
    Canver, Matthew C.
    Pinello, Luca
    Bauer, Daniel E.
    Akashi, Koichi
    Maeda, Takahiro
    BLOOD, 2019, 134
  • [23] CRISPR-Cas9/phosphoproteomics identifies multiple noncanonical targets of myosin light chain kinase
    Isobe, Kiyoshi
    Raghuram, Viswanathan
    Krishnan, Laya
    Chou, Chung-Lin
    Yang, Chin-Rang
    Knepper, Mark A.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2020, 318 (03) : F600 - F616
  • [24] IDENTIFICATION OF NOVEL TARGETS IN GLIOBLASTOMA STEM CELLS THROUGH CRISPR-CAS9 SCREENING
    Xie, Qi
    Prager, Briana
    Rich, Jeremy
    NEURO-ONCOLOGY, 2017, 19 : 228 - 229
  • [25] Co-expression of AML1-ETO and PML-RARa following treatment of de novo acute myeloid leukemia with AML1-ETO
    Zhang, Shuling
    Zhou, Wei
    Li, Yanchun
    Yu, Shuili
    Xue, Mingming
    Qiao, Yanhong
    Jian, Jinli
    Liu, Bei
    Wang, Degui
    LEUKEMIA & LYMPHOMA, 2019, 60 (05) : 1316 - 1319
  • [26] Molecular characterization of genomic AML1-ETO fusions in childhood leukemia
    Xiao, Z
    Greaves, MF
    Buffler, P
    Smith, MT
    Segal, MR
    Dicks, BM
    Wiencke, JK
    Wiemels, JL
    LEUKEMIA, 2001, 15 (12) : 1906 - 1913
  • [27] Molecular characterization of genomic AML1-ETO fusions in childhood leukemia
    Z Xiao
    MF Greaves
    P Buffler
    MT Smith
    MR Segal
    BM Dicks
    JK Wiencke
    JL Wiemels
    Leukemia, 2001, 15 : 1906 - 1913
  • [28] CRISPR-Cas9 knockout screening for functional genomics
    SHEN ZhongFu
    OU GuangShuo
    Science China(Life Sciences), 2014, 57 (07) : 733 - 734
  • [29] Prognostic Factors in Children with AML1-ETO (+) Acute Myeloid Leukemia
    Lee, J. W.
    Kim, S.
    Jang, P. S.
    Chung, N. G.
    Cho, B.
    Kim, K. E.
    Shin, J.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S189 - S190
  • [30] NHR4 domain mutations of ETO are probably very infrequent in AML1-ETO positive myeloid leukemia cells
    Hackanson, B.
    Abdelkarim, M.
    Jansen, J. H.
    Luebbert, M.
    LEUKEMIA, 2010, 24 (04) : 860 - 861
12345